Corvus Pharmaceuticals, Inc.

Q1 2020 13F Holders

Symbol
CRVS
CUSIP
221015100
Type
Equity
Class
COM
Num filers
44
Total reported value, excl. options
$43.6M
Manager Report Date Value ($000) Shares Option Type